This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Piroxicam

Read time: 1 mins
Marketing start date: 22 Dec 2024

Summary of product characteristics


Effective Time

20231004

Version

5

Spl Product Data Elements

Piroxicam Piroxicam PIROXICAM PIROXICAM D&C YELLOW NO. 10 FD&C BLUE NO. 1 FD&C RED NO. 40 FERRIC OXIDE YELLOW GELATIN LACTOSE MONOHYDRATE MAGNESIUM STEARATE POTASSIUM HYDROXIDE PROPYLENE GLYCOL SHELLAC SODIUM LAURYL SULFATE STARCH, CORN TITANIUM DIOXIDE DARK GREEN-LIGHT GREEN CAPSULE 742 Piroxicam Piroxicam PIROXICAM PIROXICAM FD&C BLUE NO. 1 FERRIC OXIDE YELLOW GELATIN LACTOSE MONOHYDRATE MAGNESIUM STEARATE POTASSIUM HYDROXIDE PROPYLENE GLYCOL SHELLAC SODIUM LAURYL SULFATE STARCH, CORN TITANIUM DIOXIDE DARK GREEN-DARK GREEN CAPSULE 743

Application Number

ANDA205585

Brand Name

Piroxicam

Generic Name

Piroxicam

Product Ndc

70771-1430

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1429-3 in bottle of 30 capsules Piroxicam Capsules, USP, 10 mg Rx only 30 capsules ZYDUS NDC 70771-1430-3 in bottle of 30 capsules Piroxicam Capsules, USP, 20 mg Rx only 30 capsules ZYDUS label label

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.